Evaluation of analgesic effects of intravenous metoclopramide versus intravenous ketorolac in patients with primary acute headache
- Conditions
- Condition 1: Migraine. Condition 2: Tension-type headache. Condition 3: Cluster headaches.MigraineTension-type headacheCluster headaches and other trigeminal autonomic cephalgias (TAC)G44.2G44.0
- Registration Number
- IRCT20151103024853N4
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 98
Patients referring to the emergency department with acute primary headache (migraine, tension, cluster)
Age: minimum 18 years old and maximum 65 years old
Pregnancy
Nursing mothers
Any active bleeding
CHF (Congestive Heart Failure)
MI (Myocardial Infarction) history
Parkinson or history of any Extrapyramidal Side Effects
Pheochromocytoma
Epilepsy and history of seizure
History of Depression
Allergy to experimented drugs
Painkillers administration before admission to the Emergency Department (ED)
??Systolic Blood pressure under 90mmHg or above 180mmHg
Heart rate under 50 beats/min or above 150 beats/min
Patients taking Antipsychotics, Promethazine, MAO inhibitors, Rivastigmine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain Visual Analogue Scale (VAS Scoring). Timepoint: Baseline, 15, 30, 60 minutes after intervention. Method of measurement: 10-cm visual analog pain scale.
- Secondary Outcome Measures
Name Time Method Patients achieved headache freedom in the ED without requiring rescue medication. Timepoint: 60 minutes after intervention. Method of measurement: Patients own statement of Headache freedom.;Patients that required rescue medication in the ED. Timepoint: 60 minutes after intervention. Method of measurement: Minor headache improvement in patients with the discretion of the treating physician.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.